$22.41
Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
Orthopediatrics Insider Sold Shares Worth $525,375, According to a Recent SEC Filing
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations
OrthoPediatrics Sees ‘Inflection Point’ as New Products Fuel Record Quarter
Overview
52-week range
$14
$27
65% of range
Avg surprise (last 2)
-7.4%
Avg reaction (last 1)
+3.6%
100% positive
Latest IV / EM
122%
EM ±21.7% · $23 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.30 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.45 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.50 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-0.11 | $-0.17 | +35.3% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.39 | $-0.26 | -50.0% | — | +3.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.34 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.26 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.34 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.20 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.13 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.30 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $59M | — | $61M | $61M | $52M | — | $55M |
| Cost of revenue | $18M | $16M | — | $16M | $17M | $14M | — | $15M |
| Gross profit | $52M | $43M | — | $45M | $44M | $38M | — | $40M |
| Operating income | $-4M | $-8M | — | $-9M | $-11M | $-11M | — | $-6M |
| Net income | $-7M | $-11M | — | $-12M | $-7M | $-11M | — | $-8M |
| EPS (diluted) | $-0.30 | $-0.45 | — | $-0.50 | $-0.30 | $-0.46 | — | $-0.34 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $17M | $12M | $20M | $17M | $45M | $33M | $44M | $51M |
| Inventory | $138M | $134M | $134M | $129M | $125M | $120M | $117M | $121M |
| Total current assets | $253M | $246M | $256M | $246M | $258M | $232M | $237M | $248M |
| Total assets | $511M | $502M | $509M | $493M | $504M | $470M | $473M | $489M |
| Long-term debt | $99M | $100M | $100M | $99M | $97M | $73M | $73M | $73M |
| Total liabilities | $168M | $163M | $162M | $144M | $148M | $123M | $119M | $118M |
| Total equity | $344M | $339M | $347M | $349M | $356M | $347M | $355M | $371M |